Pentobarbital will decrease the extent or influence of elbasvir/grazoprevir by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. The therapeutic effect of elbasvir/grazoprevir may be reduced if coadministered with potent CYP3A inducers and is also consequently contraindicated. Elderly or debilitated individuals could react to barbiturates with marked melancholy, ... https://dantenhyma.blazingblog.com/31057228/the-5-second-trick-for-is-nembutal-legal-in-usa